论文部分内容阅读
应用国产米非司酮序贯合并前列腺素终止早期妊娠已逐渐为要求终止早孕的妇女所接受。为寻找最低有效剂量,我们对米非司酮进行减量,观察了50mg米非司酮序贯合并米索前列醇600μg终止早孕的临床经过及疗效,并与国家推荐的米非司酮终止早孕用量150mg～200mg作比较,探讨低剂量米非司酮终止早孕的可行性及其经济价值。 资料和方法 一、对象及分组 1996年7月～1997年2月,对330例身体健康,年龄16～44岁,停经≤84天,经妇科检查、尿β-hCG及B超检查证实为正常宫内妊娠,无终止妊
The application of domestic mifepristone sequential merger of prostaglandins to terminate early pregnancy has gradually been accepted by women requesting termination of early pregnancy. To find the lowest effective dose, we reduced the amount of mifepristone, observed 50mg mifepristone sequential misoprostol 600μg termination of early pregnancy clinical efficacy and efficacy, and with the national recommendation of mifepristone to terminate early pregnancy Dosage 150mg ~ 200mg for comparison, to explore the feasibility of low-dose mifepristone termination of pregnancy and its economic value. Materials and Methods 1. Subjects and Groups From July 1996 to February 1997, 330 healthy individuals aged 16-44 years and menopause ≤84 days were confirmed as normal by gynecological examinations, urinary β-hCG and B-ultrasound Intrauterine pregnancy, no termination of pregnancy